Skip to main content

Table 2 Clinicopathological characteristics

From: Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types

Variable

PDAC

uMAC

SRC

P- value

n= 1002

n= 54

n= 320

 

Age, years (mean ± SD)

54.6 ± 12.8

57.3 ± 12.1

52.4 ± 12.0

0.003

Gender, n (%)

    

 Male

605 (60.4)

35 (64.8)

187 (58.4)

0.637

 Female

397 (39.6)

19 (35.2)

133 (41.6)

 

Multiplicity, n (%)

    

 Single

982 (98.0)

53 (98.1)

316 (98.8)

0.612

 Multiple

20 (2.0)

1 (1.9)

4 (1.3)

 

Tumor location, n (%)

    

 Upper

108 (10.8)

4 (7.4)

22 (6.9)

0.184

 Middle

392 (39.1)

17 (31.5)

141 (44.1)

 

 Lower

452 (45.1)

31 (57.4)

139 (43.4)

 

 Whole

50 (5.0)

2 (3.7 %)

18 (5.6)

 

Tumor size, cm (mean ± SD)

5.7 ± 3.7

7.1 ± 3.8

4.8 ± 3.2

<0.001

Lauren, n (%)

    

 Intestinal type

0 (0)

0 (0)

0 (0)

<0.001

 Diffuse type

782 (78.0)

37 (68.5)

290 (90.6)

 

Mixed type

220 (22.0)

17 (31.5)

30 (9.4)

 

Lymphatic invasion, n (%)

    

 Present

607 (60.6)

42 (77.8)

120 (37.5)

<0.001

 Absent

395 (39.4)

12 (22.2)

200 (62.5)

 

Vascular invasion, n (%)

    

 Present

105 (10.5)

12 (22.2)

27 (8.4)

0.009

 Absent

897 (89.5)

42 (77.8)

293 (91.6)

 

Perineural invasion, n (%)

    

 Present

490 (48.9)

29 (53.7)

108 (33.8)

<0.001

 Absent

512 (51.1)

25 (46.3)

212 (66.3)

 

Depth of invasion, n (%)

    

 T1

248 (24.8)

3 (5.6)

164 (51.3)

<0.001

 T2

152 (15.2)

4 (7.4)

32 (10.0)

 

 T3

242 (24.2)

13 (24.1)

40 (12.5)

 

 T4

360 (35.9)

34 (63.0)

84 (26.3)

 

Lymph node metastasis, n (%)

    

 N0

422 (42.1)

9 (16.7)

201 (62.8)

<0.001

 N1

134 (13.4)

11 (20.4)

25 (7.8)

 

 N2

131 (13.1)

10 (18.5)

27 (8.4)

 

 N3

315 (31.4)

24 (44.4)

67 (20.9)

 

Pathological stage, n (%)

    

 I

323 (32.2)

4 (7.4)

180 (56.3)

<0.001

 II

212 (21.2)

11 (20.4)

50 (15.6)

 

 III

354 (35.3)

30 (55.6)

64 (20.2)

 

 IV

113 (11.3)

9 (16.7)

26 (8.1)